HTR1B and DR3/5 receptors were consistently upregulated in a wide series of MDS patients diagnosed with different MDS subtypes, similar to previous description in AML patients23,24, and this finding was also observed among CMML specimens. This evidence concerns the gene TNFRSF25 and chronic myelomonocytic leukemia.